Menu Skip to Content

Stephen L Graziano, MD, 315 464-4353

Stephen L Graziano, MD
Appointed 07/01/85
Women's Health Network
2272 Regional Oncology Center
750 East Adams Street
Syracuse, NY 13210
315 464-4353

Current Appointments

  • Professor of Medicine
  • Division Chief of Medicine

Hospital Campus

  • Downtown

Clinical Section Affiliations

  • Medicine: Hematology and Oncology
  • Upstate Cancer Center: Medical Oncology

Research Programs and Affiliations

  • Medicine

Featured Video


Education & Fellowships

  • Fellowship: University Hospital, SUNY Health Science Center at Syracuse, 1985
  • Residency: University Hospital, SUNY Health Science Center at Syracuse, 1982
  • Internship: University Hospital, SUNY Health Science Center at Syracuse, 1980
  • MD: University of Minnesota Medical School, 1979

Clinical Interests

  • Lung cancer and Thoracic Malignancies

    Prognostic Factors in Patients with Non-Small Cell Lung Cancer; lung cancer clinical trials; participation in the Alliance for Clinical Trials in Oncology. 

Education Interests

  • Clinical Trials 

    Solid Tumor Biology

Research Interests

  • Participation in the Alliance for Clinical Trials in Oncology
    (Principal Investigator).

Clinical Trials

  • AFT-09: Randomized Phase II Trial Evaluating the Optimal Sequencing of PD-1 Inhibition with Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in Patients with Chemotherapy Naive stage IV Non-small Cell Lung Cancer
    Read more
  • Alliance A081105 - Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)
    Read more
  • EA5142 - Adjuvant Nivolumab in Resected Lung Cancers (ANVIL) - A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
    Read more
  • ECOG E4512 - A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
    Read more
  • RTOG 1306 - A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer (NSCLC)
    Read more
  • S1400 Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer
    Read more
  • S1404: A Phase III Randomized Trial Comparing High Dose Interferon to MK-3475 (Pembrolizumab) in Patients with High Risk Resected Melanoma
    Read more

Specialties & Certification

  • Internal Medicine
  • Oncology
  • Hematology

Diseases & Conditions Treated

  • All Cancers and Hematological Conditions
  • Lung Cancer
  • Mesothelioma


  • Adults


  • Apheresis
  • Blood Transfusion
  • Bone Marrow Aspiration
  • Bone Marrow Biopsy
  • Bone Marrow Transplantation (BMT)
  • Chemotherapy
  • Clinical Trials
  • Conscious Sedation
  • Infusional Therapies
  • Lumbar Puncture
  • Paracentesis
  • Stem Cell Collection Procedures
  • Stem Cell Transplantation
  • Thoracentesis


  • American Society of Clinical Oncology - ASCO
  • Alliance For Clinical Trials In Onconology
  • Thoracic Malignancy Steering Committee Of The National Cancer Institute

Current Hospital Privileges

  • Upstate University Hospital

HealthLink on Air Radio Interview


Link to PubMed External Icon (Opens new window. Close the PubMed window to return to this page.)

Research Abstract

Clinical Profile Shortcut:
Faculty Profile Shortcut: